General Info
Hakan Goker, Managing Director at M Ventures, heads the Biotechnology Investments covering Healthcare and Life Sciences. He has invested in several companies such as Asceneuron, F-Star Therapeutics, Ribometrix, and Storm Therapeutics. His expertise spans 18 years in the sector, with previous experience at Aescap Venture and Atlas Venture. The investment check size for M Ventures is â¬600 million, and Hakan Goker’s collaboration style focuses on innovation in drug discovery. He is known for active participation and guidance in portfolio companies.
Location: Amsterdam, Netherlands
Country: Türkiye
Industries: Biotechnology, Technology, Healthcare drug development, Life Science tools, Electronics, Frontier Technology, Sustainability
Investment Regions: EU
Investment Stages: pre-seed, seed
Website: https://www.m-ventures.com/en
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Found a press release showing M Ventures (Hakan Goker) as founding investor in Asceneuron’s $100M Series C dated July 16, 2024. That investment is within less than 6 months prior to the reference date, and the startup invested was Asceneuron.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Hakan Goker
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI